Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Cabut Coordinates Metabolism and Clock in Response to Nutrient Sensing

By LabMedica International staff writers
Posted on 01 Jun 2015
Using a Drosophila fruit fly model to study sugar sensing, researchers have discovered that the transcription factor and developmental growth regulator, cabut, coordinates energy metabolism as well as the circadian clock in response to sugar sensing.

Sugar feeding in flies leads to a sugar-sensing pathway that along one branch induces expression of specific genes, but also triggers a repression branch of the sugar-sensing transcriptional network via cabut (CBT, encoded by cbt) in Drosophila melanogaster. More...
However, mechanisms of transcriptional repression upon sugar sensing have remained elusive. In the new collaborative study of response to sugar, a team of researchers, led by Prof. Ville Hietakangas of the University of Helsinki (Helsinki, Finland) and Prof. Sebastian Kadener of the Hebrew University of Jerusalem (Jerusalem, Israel), found that induction of cbt represses accumulation of several metabolic targets and provides a regulatory link between nutrient sensing and the circadian clock.

Among the metabolic targets, CBT was found to repress the expression of both isoforms of the enzyme phosphoenolpyruvate carboxykinase (PEPCK). They also found that upon sugar feeding cbt is rapidly induced through direct regulation by the Mondo‐Mlx transcription factor complex. Deregulation of pepck1 in mlx mutants was found to underly the imbalance of glycerol and glucose metabolism as well as the developmental lethality of these mutants.

In addition to a subset of metabolic genes per se, the researchers found that CBT also targets a subset of genes regulated by the circadian clock and represses the cycling of metabolic target genes of this clock. They observed that perturbation of CBT levels even led to deregulation of the circadian transcriptome and circadian behavioral patterns.

The study, by Bartok O, Mari Teesalu, et al, was published online April 27, 2015, in EMBO Journal.

Related Links:

University of Helsinki
Hebrew University of Jerusalem



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Homocysteine Quality Control
Liquichek Homocysteine Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.